Trials / Completed
CompletedNCT05317312
Study of MR-107A-02 in the Treatment of Post Surgical Dental Pain.
A Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Response Study of MR-107A-02 in the Treatment of Post Surgical Dental Pain.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 111 (actual)
- Sponsor
- Mylan Specialty, LP · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
MR-107A-02 is being studied to investigate its efficacy, safety and dose-response after dental surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MR-107A-02 | MR-107A-02 oral tablet |
| DRUG | Placebo | Placebo oral tablet |
Timeline
- Start date
- 2022-03-31
- Primary completion
- 2022-06-15
- Completion
- 2022-06-20
- First posted
- 2022-04-07
- Last updated
- 2023-08-07
- Results posted
- 2023-08-07
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05317312. Inclusion in this directory is not an endorsement.